Press Releases Feb. 12, 2026 PsiThera to Participate in Piper Sandler Virtual Novel Targets in Immunology Symposium Dec. 10, 2025 PsiThera Unveiled with Newly Appointed CEO and $47.5 Million Series A to Advance Oral Medicines for Validated I&I Targets